Morad K. Nakhleh
Lead Breath Biomarker Scientist at Owlstone Medical.
Owlstone Medical has developed a breathalyzer for disease. Our vision is to change the way we currently diagnose and monitor serious disease; we aim to be become the global leader in the non-invasive detection of cancer, infectious disease and inflammatory disease. Through early detection we have set ourselves a goal to save 100,000 lives and $1.5B in health care costs.
My main task, as part of the Clinical Science team, is to design, review and follow-up on the biomedical-translational phase of our studies. Our mission is to translate the R&D developments into operational, clinically-oriented systems and to put them to the test, under real-world conditions via multi-centered clinical trials.
Visit website: https://www.apollo.io/people/Morad/Nakhleh/5ad6f249a6da98e3def2b9d7
See also: Owlstone Medical - Company focused to development of non-invasive diagnostics for cancer and inflammatory diseases.
Morad K. Nakhleh News
Nanoarray sniffs out and distinguishes ‘breathprints’ of multiple diseases
Kurzweil Network - 23-Dec-2016
International team of scientists have identified a unique “breathprint” for 17 diseases with 86% ...Read more...